Schizophrenia patients who previously used cannabis showed different brain activation patterns during cognitive tasks
Schizophrenia patients with previous cannabis use showed better brain activation during cognitive tasks and less default-mode network activity during rest, compared to patients who never used cannabis.
Quick Facts
What This Study Found
Twenty-six schizophrenia patients were divided into previous cannabis users and never-users and compared during an auditory attention task (dichotic listening) using fMRI. During the cognitive task, previous cannabis users showed remaining brain activations in effort-mode regions that were not seen in the no-cannabis group.
Conversely, during rest periods (task-absent condition), the no-cannabis group showed remaining activation in default-mode regions not seen in the cannabis group. This meant cannabis-using patients were better at "switching on" during tasks and "switching off" during rest.
The authors interpreted this as cannabis-using schizophrenia patients having lower neurocognitive vulnerability, consistent with previous behavioral studies showing better cognitive performance in cannabis-using patients.
Key Numbers
26 schizophrenia patients. Cannabis users: better task-related activation, less default-mode activation at rest. No-cannabis group: less task activation, more default-mode activation at rest.
How They Did This
Cross-sectional fMRI study of 26 schizophrenia patients (DSM-IV and ICD-10 criteria) grouped by cannabis use history. Auditory dichotic listening task with instructions to focus attention on right or left ear. Brain activation compared during task-present and task-absent conditions.
Why This Research Matters
The finding that cannabis-using schizophrenia patients showed more normal brain activation patterns supported the hypothesis that they represent a distinct subgroup with lower inherent cognitive vulnerability who may have been pushed into psychosis by cannabis rather than by severe underlying neurodevelopmental problems.
The Bigger Picture
This aligned with the "two-hit" model of psychosis: some patients develop schizophrenia primarily from genetic/neurodevelopmental vulnerability (and show worse cognition), while others with lower vulnerability are pushed into psychosis by environmental triggers like cannabis (and show better baseline cognition).
What This Study Doesn't Tell Us
Small sample (26 patients). Cross-sectional design cannot determine whether cognitive differences predate or result from cannabis use. Previous cannabis use was self-reported. No healthy control group for comparison. Cannot rule out other substance use effects.
Questions This Raises
- ?Do cannabis-using schizophrenia patients have genuinely better long-term cognitive outcomes?
- ?Would removing cannabis trigger lead to faster recovery in this subgroup?
- ?Can brain activation patterns predict treatment response?
Trust & Context
- Key Stat:
- Cannabis-using patients better at "switching on" for cognitive tasks
- Evidence Grade:
- Small cross-sectional fMRI study without healthy controls. Preliminary but adds neuroimaging support to behavioral findings of better cognition in cannabis-using psychosis patients.
- Study Age:
- Published in 2012. The cognitive paradox in cannabis-using schizophrenia patients continues to be studied.
- Original Title:
- An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use.
- Published In:
- Frontiers in psychiatry, 3, 94 (2012)
- Authors:
- Løberg, Else-Marie, Nygård, Merethe, Berle, Jan Øystein, Johnsen, Erik, Kroken, Rune A, Jørgensen, Hugo A, Hugdahl, Kenneth
- Database ID:
- RTHC-00582
Evidence Hierarchy
A snapshot of a population at one point in time.
What do these levels mean? →Frequently Asked Questions
Why would cannabis users with schizophrenia have better brain function?
The leading explanation is not that cannabis improved their brains, but that they started with better cognitive function. Cannabis may trigger psychosis in people who otherwise have healthier brains, while people with worse underlying brain function develop psychosis without needing cannabis as a trigger.
Does this mean cannabis protects the brain?
No. The interpretation is that cannabis-using patients had higher baseline cognitive function before their psychosis. Cannabis likely contributed to their psychosis onset, but their underlying neurocognitive health was better than patients who developed psychosis without cannabis exposure.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-00582APA
Løberg, Else-Marie; Nygård, Merethe; Berle, Jan Øystein; Johnsen, Erik; Kroken, Rune A; Jørgensen, Hugo A; Hugdahl, Kenneth. (2012). An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use.. Frontiers in psychiatry, 3, 94. https://doi.org/10.3389/fpsyt.2012.00094
MLA
Løberg, Else-Marie, et al. "An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use.." Frontiers in psychiatry, 2012. https://doi.org/10.3389/fpsyt.2012.00094
RethinkTHC
RethinkTHC Research Database. "An fMRI Study of Neuronal Activation in Schizophrenia Patien..." RTHC-00582. Retrieved from https://rethinkthc.com/research/loberg-2012-an-fmri-study-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.